GenMark Diagnostics, Inc. (GNMK) - Product Pipeline Analysis, 2016 Update

Date: June 8, 2016
Pages: 41
Price:
US$ 750.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: GA66FABC0FEEN
Leaflet:

Download PDF Leaflet

GenMark Diagnostics, Inc. (GNMK) - Product Pipeline Analysis, 2016 Update
Summary

GenMark Diagnostics, Inc. (GenMark) is a medical device company that offers clinical testing solutions. The company’s products include XT-8 systems and assays. It offers pipeline products such as eSensor 2C 19 genotyping test, eSensor 3A4/3A5 genotyping test, eSensor HCV genotyping test and eSensor HCVg direct test. GenMark develops products in the areas of genetics, pharmacogenetics, infectious disease and oncology. The company provides educational resources to medical professionals in the areas of cystic fibrosis, respiratory viral panel, thrombophilia and warfarin sensitivity. It has operations in the US and Switzerland. GenMark is headquartered in Carlsbad, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company GenMark Diagnostics, Inc.
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
GenMark Diagnostics, Inc. Company Snapshot
GenMark Diagnostics, Inc. Company Overview
GenMark Diagnostics, Inc. Pipeline Products and Clinical Trials Overview
GenMark Diagnostics, Inc. – Pipeline Analysis Overview
Key Facts
GenMark Diagnostics, Inc. - Major Products and Services
GenMark Diagnostics, Inc. Pipeline Products by Development Stage
GenMark Diagnostics, Inc. Pipeline Products Overview
2D6 Tamoxifen Metabolism Test
2D6 Tamoxifen Metabolism Test Product Overview
ePlex - Central Nervous System Infection Panel
ePlex - Central Nervous System Infection Panel Product Overview
ePlex System
ePlex System Product Overview
ePlex System - Fungal Infection Panel
ePlex System - Fungal Infection Panel Product Overview
ePlex System - Gastro Intestinal Test Panel
ePlex System - Gastro Intestinal Test Panel Product Overview
ePlex System - Gram Negative Bacterial Test
ePlex System - Gram Negative Bacterial Test Product Overview
ePlex System - Gram Positive Bacterial Test
ePlex System - Gram Positive Bacterial Test Product Overview
ePlex System - HCV Genotyping Test
ePlex System - HCV Genotyping Test Product Overview
ePlex System - RVP Test
ePlex System - RVP Test Product Overview
eSensor 2C19 Genotyping Test
eSensor 2C19 Genotyping Test Product Overview
eSensor 3A4/3A5 Genotyping Test
eSensor 3A4/3A5 Genotyping Test Product Overview
eSensor HCV Genotyping Test
eSensor HCV Genotyping Test Product Overview
eSensor HCVg Direct Test
eSensor HCVg Direct Test Product Overview
eSensor KRAS Test
eSensor KRAS Test Product Overview
Fully Integrated In-Vitro Diagnostic Platform
Fully Integrated In-Vitro Diagnostic Platform Product Overview
XT-8 System - Cancer Assay
XT-8 System - Cancer Assay Product Overview
XT-8 System - Genetic Diseases Assay
XT-8 System - Genetic Diseases Assay Product Overview
XT-8 System - Infectious Diseases Assay
XT-8 System - Infectious Diseases Assay Product Overview
XT-8 System - Pharmacogenetics Assay
XT-8 System - Pharmacogenetics Assay Product Overview
GenMark Diagnostics, Inc. - Key Competitors
GenMark Diagnostics, Inc. - Key Employees
GenMark Diagnostics, Inc. - Locations And Subsidiaries
Head Office
Recent Developments
GenMark Diagnostics, Inc., Recent Developments
May 03, 2016: GenMark Reports First Quarter 2016 Results
Feb 23, 2016: GenMark Reports Fourth Quarter and Full Year 2015 Results
Jan 12, 2016: GenMark Announces Preliminary Q4 Financial Results and Initiation of ePlex Analytical Studies
Oct 27, 2015: GenMark Diagnostics Reports Q3 Financial Results
Aug 06, 2015: GenMark Diagnostics Reports Q2 Financial Results
May 05, 2015: GenMark Diagnostics Reports Q1 Financial Results
Apr 16, 2015: GenMark Announces Positive Preliminary Q1 Financial Results and ePlex Update
Apr 16, 2015: GenMark Announces ePlex Update
Feb 24, 2015: GenMark Reports Fourth Quarter and Full Year 2014 Results
Feb 23, 2015: GenMark Announces Appointment of New Board Members
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

GenMark Diagnostics, Inc. Pipeline Products and Clinical Trials Overview
GenMark Diagnostics, Inc. Pipeline Products by Equipment Type
GenMark Diagnostics, Inc. Pipeline Products by Indication
GenMark Diagnostics, Inc., Key Facts
GenMark Diagnostics, Inc., Major Products and Services
GenMark Diagnostics, Inc. Number of Pipeline Products by Development Stage
GenMark Diagnostics, Inc. Pipeline Products Summary by Development Stage
2D6 TAMOXIFEN METABOLISM TEST - PRODUCT STATUS
2D6 TAMOXIFEN METABOLISM TEST - PRODUCT DESCRIPTION
ePlex - Central Nervous System Infection Panel - Product Status
ePlex - Central Nervous System Infection Panel - Product Description
ePlex System - Product Status
ePlex System - Product Description
ePlex System - Fungal Infection Panel - Product Status
ePlex System - Fungal Infection Panel - Product Description
ePlex System - Gastro Intestinal Test Panel - Product Status
ePlex System - Gastro Intestinal Test Panel - Product Description
ePlex System - Gram Negative Bacterial Test - Product Status
ePlex System - Gram Negative Bacterial Test - Product Description
ePlex System - Gram Positive Bacterial Test - Product Status
ePlex System - Gram Positive Bacterial Test - Product Description
ePlex System - HCV Genotyping Test - Product Status
ePlex System - HCV Genotyping Test - Product Description
ePlex System - RVP Test - Product Status
ePlex System - RVP Test - Product Description
eSensor 2C19 Genotyping Test - Product Status
eSensor 2C19 Genotyping Test - Product Description
eSensor 3A4/3A5 Genotyping Test - Product Status
eSensor 3A4/3A5 Genotyping Test - Product Description
eSensor HCV Genotyping Test - Product Status
eSensor HCV Genotyping Test - Product Description
eSensor HCVg Direct Test - Product Status
eSensor HCVg Direct Test - Product Description
eSensor KRAS Test - Product Status
eSensor KRAS Test - Product Description
Fully Integrated In-Vitro Diagnostic Platform - Product Status
Fully Integrated In-Vitro Diagnostic Platform - Product Description
XT-8 System - Cancer Assay - Product Status
XT-8 System - Cancer Assay - Product Description
XT-8 System - Genetic Diseases Assay - Product Status
XT-8 System - Genetic Diseases Assay - Product Description
XT-8 System - Infectious Diseases Assay - Product Status
XT-8 System - Infectious Diseases Assay - Product Description
XT-8 System - Pharmacogenetics Assay - Product Status
XT-8 System - Pharmacogenetics Assay - Product Description
GenMark Diagnostics, Inc., Key Employees

LIST OF FIGURES

GenMark Diagnostics, Inc. Pipeline Products by Equipment Type
GenMark Diagnostics, Inc. Pipeline Products by Development Stage

COMPANIES MENTIONED

Nanosphere, Inc.
Luminex Corporation
Illumina, Inc.
Epinex Diagnostics, Inc.
Cepheid
Skip to top


Ask Your Question

GenMark Diagnostics, Inc. (GNMK) - Product Pipeline Analysis, 2016 Update
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: